Literature DB >> 19549901

Suppression of nonhomologous end joining repair by overexpression of HMGA2.

Angela Y J Li1, Lee Ming Boo, Shih-Ya Wang, H Helen Lin, Clay C C Wang, Yun Yen, Benjamin P C Chen, David J Chen, David K Ann.   

Abstract

Understanding the molecular details associated with aberrant high mobility group A2 (HMGA2) gene expression is key to establishing the mechanism(s) underlying its oncogenic potential and effect on the development of therapeutic strategies. Here, we report the involvement of HMGA2 in impairing DNA-dependent protein kinase (DNA-PK) during the nonhomologous end joining (NHEJ) process. We showed that HMGA2-expressing cells displayed deficiency in overall and precise DNA end-joining repair and accumulated more endogenous DNA damage. Proper and timely activation of DNA-PK, consisting of Ku70, Ku80, and DNA-PKcs subunits, is essential for the repair of DNA double strand breaks (DSB) generated endogenously or by exposure to genotoxins. In cells overexpressing HMGA2, accumulation of histone 2A variant X phosphorylation at Ser-139 (gamma-H2AX) was associated with hyperphosphorylation of DNA-PKcs at Thr-2609 and Ser-2056 before and after the induction of DSBs. Also, the steady-state complex of Ku and DNA ends was altered by HMGA2. Microirradiation and real-time imaging in living cells revealed that HMGA2 delayed the release of DNA-PKcs from DSB sites, similar to observations found in DNA-PKcs mutants. Moreover, HMGA2 alone was sufficient to induce chromosomal aberrations, a hallmark of deficiency in NHEJ-mediated DNA repair. In summary, a novel role for HMGA2 to interfere with NHEJ processes was uncovered, implicating HMGA2 in the promotion of genome instability and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549901      PMCID: PMC2737594          DOI: 10.1158/0008-5472.CAN-08-4833

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

Review 1.  The mechanism of human nonhomologous DNA end joining.

Authors:  Michael R Lieber
Journal:  J Biol Chem       Date:  2007-11-12       Impact factor: 5.157

2.  Formation of NHEJ-derived reciprocal chromosomal translocations does not require Ku70.

Authors:  David M Weinstock; Erika Brunet; Maria Jasin
Journal:  Nat Cell Biol       Date:  2007-08       Impact factor: 28.824

Review 3.  Antigen receptor diversification and chromosome translocations.

Authors:  Mila Jankovic; André Nussenzweig; Michel C Nussenzweig
Journal:  Nat Immunol       Date:  2007-08       Impact factor: 25.606

Review 4.  Oncogenic HMGA2: short or small?

Authors:  Andrew R J Young; Masashi Narita
Journal:  Genes Dev       Date:  2007-05-01       Impact factor: 11.361

Review 5.  Tetraploidy, aneuploidy and cancer.

Authors:  Neil J Ganem; Zuzana Storchova; David Pellman
Journal:  Curr Opin Genet Dev       Date:  2007-02-26       Impact factor: 5.578

Review 6.  The HMGA proteins: a myriad of functions (Review).

Authors:  Isabelle Cleynen; Wim J M Van de Ven
Journal:  Int J Oncol       Date:  2008-02       Impact factor: 5.650

Review 7.  Roles of HMGA proteins in cancer.

Authors:  Alfredo Fusco; Monica Fedele
Journal:  Nat Rev Cancer       Date:  2007-12       Impact factor: 60.716

8.  let-7 regulates self renewal and tumorigenicity of breast cancer cells.

Authors:  Fengyan Yu; Herui Yao; Pengcheng Zhu; Xiaoqin Zhang; Qiuhui Pan; Chang Gong; Yijun Huang; Xiaoqu Hu; Fengxi Su; Judy Lieberman; Erwei Song
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

9.  Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.

Authors:  Chang-Shi Chen; Yu-Chieh Wang; Hsiao-Ching Yang; Po-Hsien Huang; Samuel K Kulp; Chih-Cheng Yang; Yen-Shen Lu; Shigemi Matsuyama; Ching-Yu Chen; Ching-Shih Chen
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

10.  Autophosphorylation of DNA-PKCS regulates its dynamics at DNA double-strand breaks.

Authors:  Naoya Uematsu; Eric Weterings; Ken-ichi Yano; Keiko Morotomi-Yano; Burkhard Jakob; Gisela Taucher-Scholz; Pierre-Olivier Mari; Dik C van Gent; Benjamin P C Chen; David J Chen
Journal:  J Cell Biol       Date:  2007-04-16       Impact factor: 10.539

View more
  34 in total

1.  The Linker Histone GH1-HMGA1 Is Involved in Telomere Stability and DNA Damage Repair.

Authors:  Cyril Charbonnel; Oleh Rymarenko; Olivier Da Ines; Fatiha Benyahya; Charles I White; Falk Butter; Simon Amiard
Journal:  Plant Physiol       Date:  2018-04-05       Impact factor: 8.340

2.  HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes.

Authors:  Jingjing Wu; Zhaojian Liu; Changshun Shao; Yaoqin Gong; Eva Hernando; Peng Lee; Masashi Narita; William Muller; Jinsong Liu; Jian-Jun Wei
Journal:  Cancer Res       Date:  2011-01-11       Impact factor: 12.701

3.  High mobility group protein-mediated transcription requires DNA damage marker γ-H2AX.

Authors:  Indrabahadur Singh; Nihan Ozturk; Julio Cordero; Aditi Mehta; Diya Hasan; Claudia Cosentino; Carlos Sebastian; Marcus Krüger; Mario Looso; Gianni Carraro; Saverio Bellusci; Werner Seeger; Thomas Braun; Raul Mostoslavsky; Guillermo Barreto
Journal:  Cell Res       Date:  2015-06-05       Impact factor: 25.617

4.  Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival.

Authors:  Yanhong Liu; Sanjay Shete; Carol J Etzel; Michael Scheurer; George Alexiou; Georgina Armstrong; Spyros Tsavachidis; Fu-Wen Liang; Mark Gilbert; Ken Aldape; Terri Armstrong; Richard Houlston; Fay Hosking; Lindsay Robertson; Yuanyuan Xiao; John Wiencke; Margaret Wrensch; Ulrika Andersson; Beatrice S Melin; Melissa Bondy
Journal:  J Clin Oncol       Date:  2010-04-05       Impact factor: 44.544

5.  Radiation damage and radioprotectants: new concepts in the era of molecular medicine.

Authors:  M I Koukourakis
Journal:  Br J Radiol       Date:  2012-01-31       Impact factor: 3.039

6.  Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk.

Authors:  Yanhong Liu; Sanjay Shete; Li-E Wang; Randa El-Zein; Carol J Etzel; Fu-Wen Liang; Georgina Armstrong; Spyros Tsavachidis; Mark R Gilbert; Kenneth D Aldape; Jinliang Xing; Xifeng Wu; Qingyi Wei; Melissa L Bondy
Journal:  Carcinogenesis       Date:  2010-07-07       Impact factor: 4.944

7.  Elevated TRIP13 drives cell proliferation and drug resistance in bladder cancer.

Authors:  Sicheng Lu; Mengjie Guo; Zhimin Fan; Ying Chen; Xuqin Shi; Chunyan Gu; Ye Yang
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

8.  Derepression of HMGA2 via removal of ZBRK1/BRCA1/CtIP complex enhances mammary tumorigenesis.

Authors:  Kazi Mokim Ahmed; Connie Y Tsai; Wen-Hwa Lee
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

9.  HMGA2 inhibits apoptosis through interaction with ATR-CHK1 signaling complex in human cancer cells.

Authors:  Suchitra Natarajan; Sabine Hombach-Klonisch; Peter Dröge; Thomas Klonisch
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

Review 10.  HMGA2 and high-grade serous ovarian carcinoma.

Authors:  Jingjing Wu; Jian-Jun Wei
Journal:  J Mol Med (Berl)       Date:  2013-05-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.